{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:50:24Z","timestamp":1756993824722,"version":"3.37.0"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":10560,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[1980,2]]},"abstract":"<jats:p>The hernodynamic eflects of prenalterol, a new inotropic agent, were investigated in 10 patients with gram negative septic shock. In four of the patients, coronary sinus blood flow (CSF) and myocardial oxygen and lactate extraction were also determined. After baseline hemodynamic measurements, prenalterol was infused intravenously over a 10\u2010min period to a total dose of 150 pg\/kg. All patients responded within 15 min after completion of prenalterol infusion by increasing mean arterial pressure from 57\u00b111 to 75 \u00b1 20 mmHg (7.58f 1.46 to 9.97\u00b12.66 kPa), (+32%), (<jats:italic>P&lt;0.01<\/jats:italic>) and cardiac index from 2.65\u00b10.40 to 3.80\u00b10.47 l min<jats:sup>\u2010l<\/jats:sup>m<jats:sup>\u20102<\/jats:sup>(+44%) (<jats:italic>P<\/jats:italic>&lt; 0.001). There was no change in heart rate or systemic vascular resistance, nor were any arrhythmias recorded. The urinary output increased significantly. After prenalterol, CSF increased from 185kl 4 to 246\u00b114 ml.min\u2010<jats:sup>1<\/jats:sup>, (+33%), (P&lt;0.001) and myocardial oxygen and lactate extraction rose from 19.8\u00b12.1to26.6\u00b12.1 ml O<jats:sub>2<\/jats:sub>.min<jats:sup>\u20101<\/jats:sup>, (+ 34%) (P&lt;0.00l) andfrom33.2\u00b12.3 to44.7k2.1 \u03bcmol.min<jats:sup>\u20101<\/jats:sup>, (+35%), (P&lt;0.001), respectively. The total body oxygen consumption increased from 287f 13 to 348\u00b123 ml O<jats:sub>2<\/jats:sub>.min<jats:sup>\u20101<\/jats:sup>, (+21 %), (<jats:italic>P&lt;0.01<\/jats:italic>) and the arterial lactate concentration decreased from 5.61\u00b10.55 to 3.94\u00b10. 16 mmol.l<jats:sup>\u20101<\/jats:sup>, (\u2010 30%), (P&lt;0.01), suggesting improved tissue perfusion. The results demonstrate that prenalterol is a potent, highly selective inotropic agent inducing the same magnitude of increase in blood pressure and cardiac output as reported for dopamine in septic shock.<\/jats:p>","DOI":"10.1111\/j.1399-6576.1980.tb01495.x","type":"journal-article","created":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T09:48:35Z","timestamp":1230803315000},"page":"5-10","source":"Crossref","is-referenced-by-count":14,"title":["Hemodynamic and Cardiometabolic Effects of Prenalterol in Patients with Gram Negative Septic Shock"],"prefix":"10.1111","volume":"24","author":[{"given":"S.","family":"Reiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.42.2.139"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00505039"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/7.4.438"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.44.2.181"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06902-9","article-title":"Cardiovascular and renal actions of dopamine: potential clinical applications","volume":"24","author":"Goldberg L. I.","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01641112"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(77)90007-X"},{"key":"e_1_2_1_9_1","first-page":"363","article-title":"Current therapy of shock","volume":"17","author":"Goldberg L. I.","year":"1971","journal-title":"Adv. int. Med."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197407000-00040"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609978"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.29.6.883"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.44.2.163"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/clinchem\/13.4.314","article-title":"Rapid enzymatic measurement of blood lactate and pyruvate","volume":"13","author":"Marbach E. P.","year":"1967","journal-title":"Clin. Chem."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197511000-00016"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01683060"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1979.tb01426.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00563552"},{"key":"e_1_2_1_19_1","first-page":"181","article-title":"Current understanding of mechanisms and treatment of circulatory shock caused by bacterial infections","volume":"9","author":"Weil M. H.","year":"1977","journal-title":"Ann. clin. Res."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-9014-9_3"},{"key":"e_1_2_1_21_1","first-page":"1280","article-title":"Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agents","volume":"231","author":"Weil M. H.","year":"1975","journal-title":"3. her. med. Ass."},{"issue":"3","key":"e_1_2_1_22_1","first-page":"207","article-title":"Transmyocardial lactate metabolism during treatment of shock with catecholamines","volume":"42","author":"Winslow E. B. J.","year":"1970","journal-title":"Circulation"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(73)90038-7"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.1980.tb01495.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.1980.tb01495.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:44:26Z","timestamp":1738863866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.1980.tb01495.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1980,2]]}},"alternative-id":["10.1111\/j.1399-6576.1980.tb01495.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.1980.tb01495.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"type":"print","value":"0001-5172"},{"type":"electronic","value":"1399-6576"}],"subject":[],"published":{"date-parts":[[1980,2]]}}}